. These results suggest that D 2 R-induced up-regulation of DAT activity occurs via a voltage-independent mechanism that depends on G i/o activation and a rapid increase in expression of functional DAT molecules at the cell surface.
crease in V max . The D 2 R-mediated enhancement of DA uptake was not associated with changes in resting membrane potential and was abolished by pertussis toxin pretreatment. Furthermore, in voltage-clamped oocytes, D 2 R activation enhanced both DA uptake and DAT-mediated steady-state currents by as much as 70%. Activation of D 2 Rs resulted in a 59% increase in cell surface binding of the cocaine analog [ 3 H]WIN 35,428; this effect was also abolished by pertussis toxin pretreatment. Saturation experiments confirmed that D 2 R activation was associated with an increased B max and unchanged K i for [ 3 H]WIN 35,428. These results suggest that D 2 R-induced up-regulation of DAT activity occurs via a voltage-independent mechanism that depends on G i/o activation and a rapid increase in expression of functional DAT molecules at the cell surface.
The dopamine transporter (DAT) belongs to a large family of neurotransmitter and amino acid transporters that are related functionally by their requirement for extracellular Na ϩ and Cl Ϫ (Uhl and Hartig, 1992; Amara and Kuhar, 1993) . DAT couples the translocation of dopamine (DA) or other substrates to the driving force of these ions down their electrochemical gradients. This transporter, which is exclusively expressed in DA neurons (Ciliax et al., 1995; Kuhar et al., 1998) , plays a critical role in regulating synaptic concentrations of DA (Giros et al., 1996) . DAT-mediated reaccumulation of DA into the presynaptic terminals terminates the synaptic actions of DA at its receptors, thus regulating the intensity, duration, and extent of dopaminergic neurotransmission. Thus, presynaptic elements such as receptors or other regulatory proteins that alter or regulate DAT function could have a profound impact on DA-mediated pre-and postsynaptic signaling.
Two DA receptor subtypes were originally proposed based on their ability to either stimulate (D 1 R) or inhibit (D 2 R) adenylyl cyclase activity (Kebabian and Calne, 1979) . To date, five distinct DA receptors have been cloned that fall into two classes: "D 1 -like" (D 1 Rs and D 5 Rs) and "D 2 -like" (D 2 Rs, D 3 Rs, and D 4 Rs) receptors (see Sokoloff and Schwartz, 1995) . Two isoforms of the D 2 R have been identified, which are encoded by a single gene and differentially spliced to include (long form) or exclude (short form) 29 amino acids within the third intracellular loop of the receptor (Giros et al., 1989; Monsma et al., 1989) . Inhibitory D 2 -like autoreceptors localized on DA neuronal terminals in brain modulate DA synthesis (Tissari et al., 1983; Wachtel et al., 1989) and release (see Starke et al., 1989) . Also, D 2 -like autoreceptors localized on the soma and dendrites of DA neurons inhibit impulse flow by activating G proteincoupled inwardly rectifying potassium channels (GIRKs), thereby hyperpolarizing the neurons (Lacey, 1993; White, 1996) . Compelling evidence that D 2 -like autoreceptors are D 2 Rs comes from reports that autoreceptor functions are lost in D 2 R-deficient mice (Mercuri et al., 1997; L'Hirondel et al., 1998) , but not in D 3 R-deficient mice (Koeltzow et al., 1998) .
There is growing evidence that D 2 Rs also participate in the presynaptic regulation of DAT activity (Meiergerd et al., 1993; Parsons et al., 1993; Cass and Gerhardt, 1994; Rothblat and Schneider, 1997; Dickinson et al., 1999; Hoffman et al., 1999) . In vivo studies showed that chronic cocaine-induced increases in striatal DA uptake were attenuated by pretreatment with a selective D 2 R antagonist (Parsons et al., 1993) . Similarly, acute or chronic administration of the D 2 R antagonist haloperidol reduces DA transport into striatal tissue in vitro, and local administration of haloperidol reduces DA uptake in vivo (Meiergerd et al., 1993; Rothblat and Schneider, 1997) . In vivo DA clearance is also decreased in striatum, nucleus accumbens, and prefrontal cortex by the selective D 2 R antagonist raclopride but not by the selective D 1 R antagonist SCH-23390 (Cass and Gerhardt, 1994) . In striatal suspensions, agonist activation of D 2 Rs increases DA uptake velocity, an effect blocked by a selective D 2 R antagonist (Meiergerd et al., 1993) ; these results provide the best evidence that the D 2 R-mediated effects on DA uptake occur via presynaptic autoreceptors. Consistent with the idea that activation of D 2 Rs increases DAT activity, in vivo DA clearance is reduced in D 2 R-deficient mice (Dickinson et al., 1999) . Thus, D 2 Rs regulate DAT function, and this regulation could represent an important mechanism by which dopaminergic neurotransmission is modulated.
The molecular mechanism by which presynaptic D 2 Rs regulate DAT function is unknown. However, the activity of human (h) DAT expressed in Xenopus laevis oocytes is sensitive to changes in membrane potential . Using electrophysiological and electrochemical techniques, Hoffman et al. (1999) recently concluded that DAT activity in rat substantia nigra is also voltage-dependent. These observations, along with the observation that presynaptic D 2 Rs can alter membrane potential through activation of GIRKs (Lacey, 1993) , suggest one mechanism by which D 2 Rs could regulate DAT function (i.e., changes in membrane potential). Investigating this type of mechanistic question is difficult in native systems, because of the numerous regulatory proteins and neural networks that must be controlled. To address this question in a simpler model system in which membrane potential could be monitored and controlled, we coexpressed the long isoform of the hD 2 R and the hDAT in oocytes. We examined D 2 R regulation of DAT activity by measuring both DAT-mediated substrate uptake and currents and DAT expression by measuring cell surface binding of [ 3 H]WIN 35,428. We found that D 2 R activation enhances DAT function by increasing the number of cell surface transporters via a G i/o -dependent mechanism and that this effect was independent of changes in membrane potential.
Experimental Procedures
Materials. cDNAs encoding the hDAT and the long isoform of the hD 2 R were provided by M. S. Sonders and S. G cRNA Preparation and Oocyte Expression. Capped cRNAs were transcribed from linearized plasmids using standard in vitro transcription reactions (mMessage mMachine; Ambion, Austin, TX). Stage V or VI X. laevis oocytes were manually defolliculated, injected with water-diluted cRNA (ϳ10 ng/oocyte), and maintained at room temperature in frog Ringers' buffer (FRB), containing 96 mM NaCl, 2 mM KCl, 1.8 mM CaCl 2 , 1 mM MgCl 2 , and 5 mM HEPES, pH 7.5, supplemented with 2.5 mM sodium pyruvate, 0.5 mM theophylline, 100 U/ml penicillin, 100 g/ml streptomycin, and 50 g/ml gentamicin. Oocytes were either coinjected with a mixture of DAT and D 2 R cRNAs on the day of oocyte isolation or injected with DAT cRNA on the day of isolation, followed 2 days later by D 2 R cRNA injection. Initially to confirm D 2 R function, voltage-clamp experiments were conducted on oocytes coexpressing D 2 R and GIRK1 (mixed and injected concurrently). GIRK1-mediated inward potassium currents were measured in FRB buffer containing 50 mM extracellular KCl. D 2 R agonists activated GIRK1-mediated currents in a manner consistent with previous reports using the oocyte expression system (Werner et al., 1996; Nelson et al., 1997) , and these currents were reversibly blocked by the D 2 R antagonist (Ϫ)-sulpiride (1 M).
DA Uptake Assays. For assays using [ 3 H]DA, oocytes were incubated in 0.5 ml of FRB containing 100 nM [ 3 H]DA for 10 min at room temperature. The oocytes were then washed three times in 5 ml of ice-cold FRB and solubilized in 0.25 ml of 2% SDS. [ 3 H]DA accumulation into individual oocytes was quantified by liquid scintillation spectroscopy. Nonspecific uptake was Ͻ2% of total uptake and was determined by incubating water-injected oocytes or cRNA-injected oocytes in the presence of a saturating concentration of mazindol (10 M).
The dependence of DAT-mediated DA uptake on membrane potential was examined in individual oocytes coexpressing DAT and D 2 R cRNAs. In these experiments, oocytes were placed in a recording chamber as described below for two-electrode, voltage-clamp studies, and then superfused with FRB at approximately 4 ml/min. FRB containing 10 M DA in the absence (D 2 R-activated) or presence of 1 M (Ϫ)-sulpiride (D 2 R-blocked) was applied for 3 min at room temperature. Membrane potential was monitored continuously. In addition, voltage-clamped (Ϫ60 mV) DA uptake was measured in oocytes from the same batch to give a direct within-batch comparison between unclamped and voltage-clamped DA uptake. After 3 min of DA exposure, the electrodes were withdrawn, and oocytes were quickly removed from the bath and washed three times in 5 ml of ice-cold FRB. The oocytes were homogenized by sonication in 2 mM perchloric acid, and the DA content of individual oocytes was quantified by HPLC with electrochemical detection. The nominal detection limit for DA was 0.5 pg/injection. DA was not detected in water-injected oocytes or DAT/D 2 R expressing oocytes that were not exposed to DA (data not shown). PTX Treatment. Oocytes were incubated in 0.5 g/ml PTX in FRB for 24 h before assay (Nelson et al., 1997) .
Two-Electrode Voltage-Clamp Recording. Electrophysiological recordings from oocytes were performed at room temperature using glass microelectrodes filled with 3 M KCl solution and an active bath probe. Oocytes were superfused with FRB buffer at approximately 4 ml/min (bath volume, 0.5 ml). A Warner OC-725B amplifier (Warner Instruments, Hamden, CT) was used with a DigiData 1200 interface. pClamp software (Axon Instruments, Foster City, CA) was used to control command voltage parameters, data acquisition, and data analysis. MacLab software and a MacLab/2e interface (AD Instruments, Milford, MA) were also used to simultaneously monitor and record electrophysiological experiments. Analog signals were low-pass-filtered at 100 Hz and digitized at 2048 Hz.
Electrophysiological recording from DAT-expressing oocytes has been described in detail previously . Briefly, oocytes were superfused with FRB buffer, and membrane potential was clamped at Ϫ60 mV. DAT-mediated currents were examined using a voltage jump protocol in which steady-state currents were measured at each of 17 command voltages (10-mV increments from Ϫ120 to ϩ40 mV). Membrane potential was held at each voltage for 400 ms. Drug-induced DAT-mediated currents were determined offline by subtracting control currents from those induced by various drug conditions (I drug Ϫ I control , by convention). The resulting subtractive currents were then plotted as a function of membrane potential, thus generating current-voltage (I-V) curves for each drug response. Fig. 1A . In these experiments, accumulation of a DAT-saturating concentration of unlabeled DA (10 M) was also measured in individual oocytes under D 2 R-blocked versus D 2 R-activated conditions while simultaneously monitoring membrane potential. In addition, before DA application, apomorphine (1 M) was applied so that membrane potential could be monitored under D 2 R-activated conditions in the absence of substrate translocation. After washout of apomorphine, under D 2 R-blocked conditions, uptake of 10 M DA was approximately 44 fmol/ s/oocyte. D 2 R activation increased DA uptake by approximately 50% ( Fig. 2A) . However, the D 2 R-mediated increase in uptake was not associated with changes in membrane potential (D 2 R-blocked ϭ Ϫ31 Ϯ 2 mV; D 2 R-activated ϭ Ϫ33 Ϯ 2 mV). The D 2 R-mediated increase in DA uptake was abolished in oocytes pretreated with PTX (bath applied; 0.5 g/ml; data not shown), suggesting that activation of G i/o proteins is involved. Voltage-clamped DA uptake experiments were also conducted to address the voltage dependence of the D 2 R-mediated increase in DA uptake. In oocytes with membrane potential clamped at Ϫ60 mV, uptake of 10 M DA was approximately 45 fmol/s/oocyte (Fig. 2B) . D 2 R activation increased DAT-mediated DA uptake by approximately 70%. Thus, because membrane potential was clamped at Ϫ60 mV, the D 2 R-mediated increase in DA uptake did not require changes in membrane potential.
Results

Effects of D 2 R Activation on DAT-
Effects of D 2 R Activation on DAT-Mediated Currents. Two-electrode, voltage-clamp experiments were per- formed with oocytes coexpressing DAT and D 2 R proteins to determine whether D 2 R activation alters DAT-mediated ionic conductances. DAT expression levels in the oocytes used in these experiments were similar to those in Fig. 1A . In DAT-expressing oocytes voltage-clamped at Ϫ60 mV, DA (10 M) induced low nA inward currents that returned to baseline after substrate washout (Fig. 3A) . Neither DA (10 M) nor (Ϫ)-sulpiride (1 M) had effects on water-injected controls (Fig. 3B) . In oocytes coexpressing D 2 R and DAT proteins under D 2 R-blocked conditions, 10 M DA induced inward currents that were similar to those observed in oocytes expressing only DAT (Fig. 3, A and C) . Sulpiride alone had no effect on baseline currents (Fig. 3C) . After a 10-min washout period, DA-induced D 2 R activation enhanced DAT-mediated inward currents significantly compared with D 2 R-blocked conditions (Fig. 3D) .
Using a voltage-jump protocol, steady-state currents were recorded over a range of holding potentials. Consistent with previous findings , at least two distinct currents were mediated by DAT (see Fig. 4A ). The first was a "transport-associated" inward current, which was induced by DAT substrates and was predominant at hyperpolarized holding potentials (Ϫ20 to Ϫ120 mV). The second was a constitutively active inward leak current, which was blocked by DAT substrates and apparent at more depolarized potentials (Ϫ10 to ϩ40 mV). Similar to DA uptake assay conditions, DAT-mediated currents were compared under D 2 R-blocked versus D 2 Ractivated conditions (Fig. 4A) . Subtractive currents (I drug Ϫ I control ) were plotted as a function of holding potential, and the current-voltage (I-V) relationships were compared. D 2 R activation by 10 M DA enhanced inward-directed, transport-associated currents across a wide range of hyperpolarized potentials (Ϫ20 to Ϫ120 mV). Similar results were obtained when tyramine (10 M) was used to induce DAT-mediated currents either in the absence (1 M (Ϫ)-sulpiride) or the presence of D 2 R activation (100 nM apomorphine; data not shown). Figure 4B shows the mean data for the effect of D 2 R activation on DATmediated currents at holding potentials of Ϫ90 or ϩ20 mV. On average, at a holding potential of Ϫ90 mV, transport-associated currents were increased by 70% by D 2 R activation (Fig. 4B) . The block of the leak current by DAT substrates was apparent at more depolarized potentials (Ϫ20 to ϩ40 mV). Although D 2 R activation had modest effects on the leak current at depolarized potentials as high as 20 mV, the robust increases in DATmediated currents at hyperpolarized potentials suggests that the primary effect of D 2 R activation is on transport-associated ionic conductances. When the effect of D 2 R activation on DATmediated currents was expressed as the percentage change from control (D 2 R-blocked) and plotted function of holding potential, the D 2 R-induced increase in DAT-mediated currents was relatively constant across a wide range of hyperpolarized potentials (Ϫ20 to Ϫ120 mV; Fig. 4C ). At the most depolarized potentials, where the leak current predominates, currents were reduced slightly by D 2 R activation (Fig. 4C) 
Discussion
There is growing evidence that D 2 Rs regulate brain DAT activity. However, the complexities of intact neuronal preparations make investigations into the molecular mechanisms involved difficult. In the present study, we used the X. laevis oocyte expression system to coexpress the hD 2 R (long isoform) and the hDAT to address the hypothesis that D 2 Rs regulate DAT activity by altering membrane potential. D 2 R activation enhanced DAT-mediated substrate translocation, as well as ionic conductances associated with substrate translocation. However, the D 2 R-mediated increases in DAT activity were independent of changes in membrane potential. D 2 R activation also increased the number of whole-cell binding sites detected with [ 3 H]WIN 35,428, suggesting that D 2 R activation enhances DAT activity by increasing the cell surface expression of DAT. These D 2 R-mediated effects likely depend on G i/o signaling, because pretreatment with PTX abolished both the enhanced function and cell surface binding of DAT.
It has been established previously that, when expressed individually in oocytes, DAT or D 2 R proteins exhibit their expected activities and pharmacological profiles. For example, the translocation kinetics of the hDAT expressed in oocytes has been characterized in detail and found to be consistent with those observed in mammalian cell lines expressing hDAT (Giros et al., 1992; Eshleman et al., 1995) . We observed similar results in oocytes coexpressing hDAT and hD 2 R proteins. Initially, we confirmed D 2 R function by coexpressing hD 2 Rs with rat GIRK1 (Kir3.1). Agonist stimulation of D 2 R-activated GIRK1-mediated potassium currents in a manner consistent with previous reports (Werner et al., 1996; Nelson et al., 1997 3 H]DA), uptake was enhanced significantly by D 2 R activation. These results demonstrate that hDAT activity can be regulated by hD 2 Rs and are consistent with reports suggesting that D 2 R ligands modulate rodent brain DAT function (Meiergerd et al., 1993; Parsons et al., 1993; Cass and Gerhardt, 1994; Rothblat and Schneider, 1997; Dickinson et al., 1999; Hoffman et al., 1999) . However, it is unclear why a D 2 R-mediated increase in DA uptake did not occur when DAT velocities were relatively higher (Ͼ3 fmol/s/oocyte, measured with 100 nM [ 3 H]DA). It is unlikely that substrate depletion reduced the effect of D 2 R activation on DA uptake in these experiments, because identical results were obtained using a saturating concentration of DA (10 M; data not shown). Regulation of the ␥-aminobutyric acid (GABA) transporter GAT1 by phorbol esters has been shown to depend on the level of protein expression (Quick et al., 1997) . Thus, it is possible that, in oocytes expressing a high number of DAT molecules, the mechanism(s) and/or signaling cascades linking D 2 Rs and DATs may be limiting, thereby saturating DAT or D 2 R protein-protein associations and leading to diminished regulatory potential. However, the magnitude of D 2 Ractivated [
3 H]DA uptake was not correlated with the level of D 2 R expression as assessed by [ 3 H](Ϫ)-sulpiride binding. DA uptake into DAT-expressing oocytes has been shown to be voltage-dependent . Consistent with this conclusion, Hoffman et al. (1999) found that activation of D 2 Rs or GABA B receptors in rat substantia nigra hyperpolarizes DA neurons and increases DAT-mediated DA clearance. Thus, a potential mechanism underlying the D 2 R-mediated increase in DA uptake would be a D 2 R-dependent change in the resting membrane potential. In brain, activa- (Lacey, 1993) . The extent to which X. laevis oocytes express endogenous potassium channels is not precisely known. However, we did not observe D 2 R-mediated changes in membrane potential (see below), suggesting that the effects of D 2 R activation on DAT function were not mediated by coupling of D 2 Rs to endogenous potassium channels. Furthermore, in a limited number of experiments, we observed no differences between D 2 R-mediated increases in [
3 H]DA uptake in oocytes coexpressing D 2 Rs, DATs, and GIRK1 channels or coexpressing only D 2 Rs and DATs (R. D. Mayfield and N. R. Zahniser, unpublished observations).
Several lines of evidence suggest that the D 2 R-mediated increases in DAT activity were independent of changes in membrane potential. The effects of D 2 R activation on membrane potential were measured directly while concurrently measuring DA uptake. Membrane potential was not changed in response to D 2 R activation; however, DA uptake was increased by as much as 50%. Also, in voltage-clamped uptake experiments, D 2 R activation increased DAT-mediated DA uptake significantly. If D 2 R-mediated increases in DA uptake depended on changes in membrane potential, D 2 R activation would not have regulated DAT activity, because membrane potential was held constant. Together, these findings and those discussed below argue strongly against D 2 R regulation of membrane potential as a mechanism underlying the enhanced DAT activity observed in these experiments.
The results from experiments measuring DAT-associated currents also argue that D 2 R activation of DAT is voltageindependent. DAT substrates induce transport-associated currents, which are Na ϩ -and voltage-dependent Sitte et al., 1998) . In voltage-clamped oocytes coexpressing D 2 R and DAT, we found that activation of D 2 Rs by DA significantly enhanced transport-associated inward currents. Similar to our findings with DA uptake, enhanced substrate-associated currents were only observed in oocytes expressing lower DAT velocities. The D 2 R-mediated increase in DAT currents were observed at holding potentials between Ϫ20 and Ϫ120 mV, and the current magnitude increased as a function of increasing hyperpolarization. Although steadystate currents at hyperpolarized potentials were voltage-dependent under both D 2 R-blocked and -activated conditions, the percentage increase in steady-state currents resulting from D 2 R activation was relatively constant over this range of holding potentials, equaling approximately 50%. This finding suggests that the increased transport-associated current induced by D 2 R activation is voltage-independent.
In contrast with the lack of effect of membrane potential on D 2 R-mediated enhancement of DAT function, pretreatment with PT abolished the effects of D 2 R activation on both DAT function and binding (see below). D 2 Rs couple to PTX-sensitive G i/o proteins to inhibit adenylyl cyclase, voltage-gated calcium channels, and protein kinase C (PKC), as well as to activate GIRKs and mitogen-activated protein kinase (see Giambalvo and Wagner, 1994; Sokoloff and Schwartz, 1995; Watts et al., 1998) . The long isoform of the D 2 R, which we investigated here, can selectively activate G o (Watts et al., 1998) . However, it remains to be determined whether the D 2 R regulation of DAT involves G i and/or G o proteins. Furthermore, D 2 R actions can be mediated by both G␣ and G␤␥ subunits (Watts et al., 1998; Choi et al., 1999) . In primate brain the short isoform of the D 2 R predominates in DA neurons (Khan et al., 1998) . Signal transduction mechanisms can differ between the long and short isoforms (Sokoloff and Schwartz, 1995; Choi et al., 1999) . Nonetheless, our findings of enhanced DAT function, mediated by the long isoform of the D 2 R in the oocyte expression system, agrees with the observations of D 2 R-mediated up-regulation of DA clearance in rodent brain.
Recent results suggest that DAT trafficking plays a prominent role in the regulation of transporter activity. For example, activation of PKC by phorbol esters decreases DAT function by reducing the number of functional transporters on the cell surface (Zhang et al., 1997; Zhu et al., 1997; see Pristupa et al., 1998) . Furthermore, the phorbol ester-induced loss of cell surface DAT is associated with increased endocytotic trafficking of the transporter (Daniels and Amara, 1999; Melikian and Buckley, 1999 (Reith and Coffey, 1993) , such as are present intracellularly in oocytes [6 mM (Barish, 1983) ]. We found that D 2 R activation increased the number of cell surface DATs by 60%, as measured by These results are consistent with a hypothesis that D 2 Rs regulate cell surface expression of DAT, thereby providing a rapid, local feedback mechanism for transporter regulation. Whether the net increase in cell surface transporters reflects reduced DAT endocytosis or increased trafficking to the cell surface remains to be determined.
In conclusion, the increase in the number of [ 3 H]WIN 35,428 binding sites, together with the enhanced DAT uptake and currents, suggest strongly that the D 2 R-induced upregulation of DAT function results from an increase in the number of functional DAT molecules expressed at the cell surface. D 2 R-mediated changes in membrane potential do not seem to be involved in this regulation of DAT function, whereas D 2 R-mediated changes in G i/o signaling do. It is possible that common mechanisms are involved in receptormediated regulation of neurotransmitter transporters. Receptors that couple to PKC via G proteins alter the activity of the norepinephrine and GABA transporters by inducing a rapid redistribution of these transporters (Apparsundaram et al., 1998; Beckman et al., 1999) . Whatever the molecular mechanism for D 2 R/DAT interactions, these findings support the idea that presynaptic D 2 Rs can alter not only DA neuronal firing, synthesis, and release, but also DA uptake.
